Insulet Issues a Medical Device Correction Notice for Insulin Pump System

Medical device maker Insulet (NASDAQ: PODD) issued a voluntary medical device correction notice for its Omnipod DASH Insulin Management System Thursday, warning that there is a remote possibility that the devices may deliver an incorrect amount of insulin, which could lead to hypoglycemia or hyperglycemia. The company will replace the devices when a software update becomes available in March.